P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-Analysis

P2Y12 inhibitor monotherapy is a feasible alternative treatment for patients after percutaneous coronary intervention (PCI) in the modern era. Clinical trials have shown that it could lower the risk of bleeding complications without increased ischemic events as compared to standard dual antiplatelet...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Wen-Han, Chang, Yong-Chieh, Lin, Yi-Hsiung, Chen, Hsiao-Ling, Chen, Chun-Yin, Lin, Tsung-Han, Lin, Tzu-Chieh, Chang, Ching-Tang, Kuo, Hsuan-Fu, Chang, Hsiu-Mei, Chu, Chih-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958698/
https://www.ncbi.nlm.nih.gov/pubmed/37259380
http://dx.doi.org/10.3390/ph16020232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958698/
https://www.ncbi.nlm.nih.gov/pubmed/37259380
http://dx.doi.org/10.3390/ph16020232

Ejemplares similares